Implementation and Outcomes Assessment of a 4-factor prothrombin complex concentrate (4F-PCC) Tiered Fixed Dosing Protocol in a Health System.

Authors

Mark Botros BS
Jamie Gaul PharmD, BCPS, Parkview HealthFollow
Dana Lorber PharmD, BCPS, Parkview HealthFollow
Sarah Koontz PharmD, BCPS, Parkview HealthFollow

Abstract

2021 ASHP Midyear Clinical Meeting / Poster

The aim of this study was to evaluate compliance to the newly implemented fixed dosing protocol while assessing for the need for repeat doses of 4F-PCC and the need for further invasive intervention to reverse the bleeding.

Document Type

Article

Publication Date

2021

Recommended Citation

Botros, Mark BS; Gaul, Jamie PharmD, BCPS; Lorber, Dana PharmD, BCPS; and Koontz, Sarah PharmD, BCPS, "Implementation and Outcomes Assessment of a 4-factor prothrombin complex concentrate (4F-PCC) Tiered Fixed Dosing Protocol in a Health System." (2021). Parkview Pharmacy Department. 54.
https://researchrepository.parkviewhealth.org/pharma/54